Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

911 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polymer-Free Drug-Coated Coronary Stents Are Cost-Effective in Patients at High Bleeding Risk: Economic Evaluation of the LEADERS FREE Trial.
Filipovic-Pierucci A, Durand-Zaleski I, Butel T, Greene S, Hovasse T, Iñiguez A, Nazzaro MS, Oldroyd KG, Talwar S, Richardt G, Windhovel U, Urban P, Morice MC. Filipovic-Pierucci A, et al. Among authors: urban p. EuroIntervention. 2018 Feb 20;13(14):1688-1695. doi: 10.4244/EIJ-D-17-00286. EuroIntervention. 2018. PMID: 28891471 Free article.
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry.
Cuculi F, Banning AP, Abizaid A, Bartorelli AL, Baux AC, Dzavík V, Ellis S, Gao R, Holmes D, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Stoll HP, Worthley S, Urban P; e-SELECT investigators. Cuculi F, et al. Among authors: urban p. EuroIntervention. 2011 Dec;7(8):962-8. doi: 10.4244/EIJV7I8A152. EuroIntervention. 2011. PMID: 22157482 Free article.
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.
Danzi GB, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez JG, Sagic D, Laanmets P, Strupp G, West N, Paunovic D; NOBORI 2 Investigators. Danzi GB, et al. Among authors: urban p. EuroIntervention. 2012 May 15;8(1):109-16. doi: 10.4244/EIJV8I1A17. EuroIntervention. 2012. PMID: 22278136 Free article.
Why are we still using coronary bare-metal stents?
Morice MC, Urban P, Greene S, Schuler G, Chevalier B. Morice MC, et al. Among authors: urban p. J Am Coll Cardiol. 2013 Mar 12;61(10):1122-3. doi: 10.1016/j.jacc.2012.11.049. Epub 2013 Jan 16. J Am Coll Cardiol. 2013. PMID: 23333139 Free article. No abstract available.
Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy.
Urban P, Abizaid A, Chevalier B, Greene S, Meredith I, Morice MC, Pocock S. Urban P, et al. Am Heart J. 2013 May;165(5):704-9. doi: 10.1016/j.ahj.2013.01.008. Epub 2013 Feb 19. Am Heart J. 2013. PMID: 23622906 Clinical Trial.
Outcomes following implantation of the Biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry.
Urban P, Valdés M, Menown I, Eberli F, Alhaddad I, Hildick-Smith D, Iosseliani D, Roffi M, Oldroyd K, Kalloudi E, Eerdmans P, Berland J, Kleber FX; e-Biomatrix investigators. Urban P, et al. Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1151-60. doi: 10.1002/ccd.25892. Epub 2015 Mar 19. Catheter Cardiovasc Interv. 2015. PMID: 25683225
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.
Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC; LEADERS FREE Investigators. Urban P, et al. N Engl J Med. 2015 Nov 19;373(21):2038-47. doi: 10.1056/NEJMoa1503943. Epub 2015 Oct 14. N Engl J Med. 2015. PMID: 26466021 Free article. Clinical Trial.
Polymer-free Drug-Coated Coronary Stents.
Urban P, Morice MC. Urban P, et al. N Engl J Med. 2016 Mar 3;374(9):893. doi: 10.1056/NEJMc1600136. N Engl J Med. 2016. PMID: 26962917 No abstract available.
Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study.
Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Greene S, Morice MC; LEADERS FREE Investigators. Naber CK, et al. Among authors: urban p. Eur Heart J. 2017 Apr 1;38(13):961-969. doi: 10.1093/eurheartj/ehw203. Eur Heart J. 2017. PMID: 27190095 Free PMC article. Clinical Trial.
2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.
Garot P, Morice MC, Tresukosol D, Pocock SJ, Meredith IT, Abizaid A, Carrié D, Naber C, Iñiguez A, Talwar S, Menown IBA, Christiansen EH, Gregson J, Copt S, Hovasse T, Lurz P, Maillard L, Krackhardt F, Ong P, Byrne J, Redwood S, Windhövel U, Greene S, Stoll HP, Urban P; LEADERS FREE Investigators. Garot P, et al. Among authors: urban p. J Am Coll Cardiol. 2017 Jan 17;69(2):162-171. doi: 10.1016/j.jacc.2016.10.009. Epub 2016 Oct 30. J Am Coll Cardiol. 2017. PMID: 27806919 Free article. Clinical Trial.
911 results